United States Synthetic Peptide Vaccine Market Report 2017

December 2017 | 99 pages | ID: U91F6FED23AEN
QYResearch

Abstracts

In this report, the United States Synthetic Peptide Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Synthetic Peptide Vaccine in these regions, from 2012 to 2022 (forecast).

United States Synthetic Peptide Vaccine market competition by top manufacturers/players, with Synthetic Peptide Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• United Biomedical
• Bionor Pharma
• Miltenyi Biotec
• Celgene Corporation
• Lytix Biopharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 1 ml
• 2.5 ml
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prostate Cancer
• Breast Cancer
• Gastric Cancer
• Lung Cancer
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Synthetic Peptide Vaccine Market Report 2017

1 SYNTHETIC PEPTIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of Synthetic Peptide Vaccine
1.2 Classification of Synthetic Peptide Vaccine by Product Category
  1.2.1 United States Synthetic Peptide Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Synthetic Peptide Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 1 ml
  1.2.4 2.5 ml
  1.2.5 Other
1.3 United States Synthetic Peptide Vaccine Market by Application/End Users
  1.3.1 United States Synthetic Peptide Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Prostate Cancer
  1.3.3 Breast Cancer
  1.3.4 Gastric Cancer
  1.3.5 Lung Cancer
  1.3.6 Other
1.4 United States Synthetic Peptide Vaccine Market by Region
  1.4.1 United States Synthetic Peptide Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Synthetic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Synthetic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Synthetic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Synthetic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Synthetic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Synthetic Peptide Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Synthetic Peptide Vaccine (2012-2022)
  1.5.1 United States Synthetic Peptide Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Synthetic Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES SYNTHETIC PEPTIDE VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Synthetic Peptide Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Synthetic Peptide Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Synthetic Peptide Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Synthetic Peptide Vaccine Market Competitive Situation and Trends
  2.4.1 United States Synthetic Peptide Vaccine Market Concentration Rate
  2.4.2 United States Synthetic Peptide Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Synthetic Peptide Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SYNTHETIC PEPTIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Synthetic Peptide Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Synthetic Peptide Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Synthetic Peptide Vaccine Price by Region (2012-2017)

4 UNITED STATES SYNTHETIC PEPTIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Synthetic Peptide Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Synthetic Peptide Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Synthetic Peptide Vaccine Price by Type (2012-2017)
4.4 United States Synthetic Peptide Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SYNTHETIC PEPTIDE VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Synthetic Peptide Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Synthetic Peptide Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SYNTHETIC PEPTIDE VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 United Biomedical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Synthetic Peptide Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 United Biomedical Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bionor Pharma
  6.2.2 Synthetic Peptide Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bionor Pharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Miltenyi Biotec
  6.3.2 Synthetic Peptide Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Miltenyi Biotec Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celgene Corporation
  6.4.2 Synthetic Peptide Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Lytix Biopharma
  6.5.2 Synthetic Peptide Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 SYNTHETIC PEPTIDE VACCINE MANUFACTURING COST ANALYSIS

7.1 Synthetic Peptide Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Synthetic Peptide Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Synthetic Peptide Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Synthetic Peptide Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SYNTHETIC PEPTIDE VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Synthetic Peptide Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Synthetic Peptide Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Synthetic Peptide Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Synthetic Peptide Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Synthetic Peptide Vaccine
Figure United States Synthetic Peptide Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure 1 ml Product Picture
Figure 2.5 ml Product Picture
Figure Other Product Picture
Figure United States Synthetic Peptide Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Synthetic Peptide Vaccine by Application in 2016
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastric Cancer Examples
Table Key Downstream Customer in Gastric Cancer
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Synthetic Peptide Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Synthetic Peptide Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Synthetic Peptide Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Synthetic Peptide Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Synthetic Peptide Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Synthetic Peptide Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Synthetic Peptide Vaccine Sales Share by Players/Suppliers
Figure United States Synthetic Peptide Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Synthetic Peptide Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Synthetic Peptide Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Synthetic Peptide Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Synthetic Peptide Vaccine Revenue Share by Players/Suppliers
Table United States Market Synthetic Peptide Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Synthetic Peptide Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Synthetic Peptide Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Synthetic Peptide Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Synthetic Peptide Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Synthetic Peptide Vaccine Product Category
Table United States Synthetic Peptide Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Synthetic Peptide Vaccine Sales Share by Region (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Share by Region (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Market Share by Region in 2016
Table United States Synthetic Peptide Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Synthetic Peptide Vaccine Revenue Share by Region (2012-2017)
Figure United States Synthetic Peptide Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Synthetic Peptide Vaccine Revenue Market Share by Region in 2016
Table United States Synthetic Peptide Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Synthetic Peptide Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Synthetic Peptide Vaccine Sales Share by Type (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Share by Type (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Market Share by Type in 2016
Table United States Synthetic Peptide Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Synthetic Peptide Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Synthetic Peptide Vaccine by Type (2012-2017)
Figure Revenue Market Share of Synthetic Peptide Vaccine by Type in 2016
Table United States Synthetic Peptide Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Synthetic Peptide Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Synthetic Peptide Vaccine Sales Market Share by Application (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Market Share by Application (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Market Share by Application in 2016
Table United States Synthetic Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Synthetic Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Table United Biomedical Basic Information List
Table United Biomedical Synthetic Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure United Biomedical Synthetic Peptide Vaccine Sales Growth Rate (2012-2017)
Figure United Biomedical Synthetic Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure United Biomedical Synthetic Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Bionor Pharma Basic Information List
Table Bionor Pharma Synthetic Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bionor Pharma Synthetic Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Bionor Pharma Synthetic Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Bionor Pharma Synthetic Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Miltenyi Biotec Basic Information List
Table Miltenyi Biotec Synthetic Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Miltenyi Biotec Synthetic Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Miltenyi Biotec Synthetic Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Miltenyi Biotec Synthetic Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Synthetic Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corporation Synthetic Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Celgene Corporation Synthetic Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Celgene Corporation Synthetic Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Lytix Biopharma Basic Information List
Table Lytix Biopharma Synthetic Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Lytix Biopharma Synthetic Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Lytix Biopharma Synthetic Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Lytix Biopharma Synthetic Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Synthetic Peptide Vaccine
Figure Manufacturing Process Analysis of Synthetic Peptide Vaccine
Figure Synthetic Peptide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Synthetic Peptide Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Synthetic Peptide Vaccine
Table Distributors/Traders List
Figure United States Synthetic Peptide Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Synthetic Peptide Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Synthetic Peptide Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Synthetic Peptide Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Synthetic Peptide Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Synthetic Peptide Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources